Frontier Medicines
Frontier Medicines is a clinical-stage biopharmaceutical company pioneering the discovery and development of small-molecule covalent drugs against disease-causing proteins long considered undruggable. Its proprietary Frontier Platform pairs chemoproteomics with artificial intelligence and machine learning and a proprietary Druggability Atlas that maps thousands of novel covalent binding opportunities across the human proteome. Lead precision oncology candidates include FMC-376 (KRAS G12C), FMC-220 (a p53 Y220C reactivator), and FMC-242 (PI3Kalpha-RAS). Founded in 2018 with offices in Boston, Massachusetts and South San Francisco, California, the company is backed by DCVC and other life-science investors. Frontier Medicines was added to the API Evangelist network as a DCVC portfolio company; it publishes no public API or developer surface, so this profile captures company identity only.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Frontier Medicines is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Frontier Medicines scores 13.0/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Frontier Medicines — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Frontier Medicines is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/frontier-medicines · machine-readable index on apis.io